SNS-INSIDER-300X300.jpg
Anticoagulation Market to Touch USD 61.49 Billion by 2030 owing to Increasing Prevalence of Cardiovascular Diseases across the Globe | Research by SNS Insider
03 avr. 2023 11h05 HE | SNS Insider pvt ltd
Pune, April 03, 2023 (GLOBE NEWSWIRE) -- As per the report by SNS Insider, the Anticoagulation Market had a worth of USD 35.25 billion in 2022, and is anticipated to attain USD 61.49 billion by...
jc_logo.jpg
Anticoagulation protocol reduces venous thromboembolisms in patients with traumatic brain injury
26 mars 2020 12h00 HE | The Joint Commission
Study in April 2020 issue of The Joint Commission Journal on Quality and Patient Safety OAKBROOK TERRACE, Ill., March 26, 2020 (GLOBE NEWSWIRE) -- Traumatic brain injury (TBI) is one of the leading...
On-X Life Technologies Inc. logo
On-X LTI Receives FDA Approval for On-X Heart Valve With Anatomic Shaped Sewing Ring
26 févr. 2013 08h00 HE | On-X Life Technologies Inc.
AUSTIN, Texas, Feb. 26, 2013 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it has received approval from the US Food & Drug Administration (FDA) to market the...
On-X Life Technologies Inc. logo
On-X LTI Launches Innovative Heart Valve Products at European Meeting in Barcelona
29 oct. 2012 08h00 HE | On-X Life Technologies Inc.
AUSTIN, Texas, Oct. 29, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is launching two new heart valve products, the On-X® Aortic Prosthetic Valve...
On-X Life Technologies Inc. logo
On-X Life Technologies Submits for FDA/CE Approval of Reduced Anticoagulation Indication for On-X Aortic Heart Valve
22 oct. 2012 08h01 HE | On-X Life Technologies Inc.
If approval is received, the On-X valve will become the first aortic valve that allows patients to be maintained at levels of anticoagulation below currently recommended professional society...
On-X Life Technologies Inc. logo
The On-X(R) Heart Valve Compares Favorably to Tissue Valves
23 mai 2012 09h00 HE | On-X Life Technologies Inc.
AUSTIN, Texas, May 23, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that results from a study comparing the On-X mechanical heart valve to tissue valves...
On-X Life Technologies Inc. logo
On-X Life Technologies Releases Expected Timelines for Reduced Anticoagulation Study Results at AATS
30 avr. 2012 07h59 HE | On-X Life Technologies Inc.
SAN FRANCISCO, April 30, 2012 (GLOBE NEWSWIRE) -- On-X® Life Technologies, Inc. (On-X LTI) announced today that it is releasing the expected timelines for the initial submission to the FDA of...